Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MagneThermoPro : Magnetic Resonance Thermography of Human Prostate

NCT: NCT04822272 · COMPLETED

NCT IDNCT04822272
StatusCOMPLETED
Start Date2022-07-08
Completion2023-06-08

Brief Summary

The objective of this project is to offer a very innovative solution for measuring temperature variations in MRI on the prostate. Multiparametric prostate MRI can detect target lesions, on which targeted biopsies are then performed. The use of a temperature mapping on the prostate in MRI would make it possible to evaluate a focal treatment of the prostate by laser under MRI guidance

Frequently Asked Questions

What is MagneThermoPro : Magnetic Resonance Thermography of Human Prostate?

MagneThermoPro : Magnetic Resonance Thermography of Human Prostate is a clinical trial registered under NCT04822272. Current status: COMPLETED.

What is the status of NCT04822272?

The current status of NCT04822272 (MagneThermoPro : Magnetic Resonance Thermography of Human Prostate) is: COMPLETED.

When did MagneThermoPro : Magnetic Resonance Thermography of Human Prostate start?

MagneThermoPro : Magnetic Resonance Thermography of Human Prostate started on 2022-07-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.